Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014 (2014), Article ID 368107, 9 pages
http://dx.doi.org/10.1155/2014/368107
Research Article

Effect of Dietary Polyunsaturated Fatty Acids on Oxidant/Antioxidant Status in Macrosomic Offspring of Diabetic Rats

1Laboratory of Physiology, Physiopathology and Biochemistry of Nutrition, Department of Biology, Faculty of Natural and Life Sciences, Earth and Universe, University of Abou Bekr Belkaid, BP 119, 13000 Tlemcen, Algeria
2Department of Technical Sciences, Faculty of Engineering, University of Abou Bekr Belkaid, 13000 Tlemcen, Algeria
3INSERM UMR 866, “Lipids Nutrition Cancer,” Faculty of Life, Earth and Environment Sciences, University of Burgundy, 21000 Dijon, France

Received 3 March 2014; Accepted 14 May 2014; Published 2 June 2014

Academic Editor: Kusum Kharbanda

Copyright © 2014 B. Guermouche et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Mohammadbeigi, F. Farhadifar, N. Soufi Zadeh, N. Mohammadsalehi, M. Rezaiee, and M. Aghaei, “Fetal macrosomia: risk factors, maternal, and perinatal outcome,” Annals of Medical & Health Sciences Research, vol. 3, no. 4, pp. 546–550, 2013. View at Publisher · View at Google Scholar
  2. M. S. Martin-Gronert and S. E. Ozanne, “Maternal nutrition during pregnancy and health of the offspring,” Biochemical Society Transactions, vol. 34, no. 5, pp. 779–782, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. H. Merzouk, S. Madani, A. Boualga, J. Prost, M. Bouchenak, and J. Belleville, “Age-related changes in cholesterol metabolism in macrosomic offspring of rats with streptozotocin-induced diabetes,” Journal of Lipid Research, vol. 42, no. 7, pp. 1152–1159, 2001. View at Google Scholar · View at Scopus
  4. D. Bonnefont-Rousselot, J. P. Bastard, M. C. Jaudon, and J. Delattre, “Consequences of the diabetic status on the oxidant/antioxidant balance,” Diabetes and Metabolism, vol. 26, no. 3, pp. 163–176, 2000. View at Google Scholar · View at Scopus
  5. S. Merzouk, A. Hichami, A. Sari et al., “Impaired oxidant/antioxidant status and LDL-fatty acid composition are associated with increased susceptibility to peroxidation of LDL in diabetic patients,” General Physiology and Biophysics, vol. 23, no. 4, pp. 387–399, 2004. View at Google Scholar · View at Scopus
  6. R. Paul Robertson, J. Harmon, P. O. T. Tran, and V. Poitout, “β-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes,” Diabetes, vol. 53, no. 1, pp. S119–S124, 2004. View at Google Scholar · View at Scopus
  7. S. Muniandy, R. Qvist, G. O. S. Yan, C. J. Bee, Y. K. Chu, and A. V. Rayappan, “The oxidative stress of hyperglycemia and the inflammatory process in endothelial cells,” Journal of Medical Investigation, vol. 56, no. 1-2, pp. 6–10, 2009. View at Google Scholar · View at Scopus
  8. H. Kolb and V. Kolb-Bachofen, “Nitric oxide: a pathogenetic factor in autoimmunity,” Immunology Today, vol. 13, no. 5, pp. 157–160, 1992. View at Google Scholar · View at Scopus
  9. L. P. Roma, S. M. Pascal, J. Duprez, and J.-C. Jonas, “Mitochondrial oxidative stress contributes differently to rat pancreatic islet cell apoptosis and insulin secretory defects after Prolonged culture in a low non-stimulating glucose concentration,” Diabetologia, vol. 55, no. 8, pp. 2226–2237, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Ceriello, “Oxidative stress and glycemic regulation,” Metabolism, vol. 49, no. 2, pp. 27–29, 2000. View at Google Scholar · View at Scopus
  11. F. Song, W. Jia, Y. Yao et al., “Oxidative stress, antioxidant status and DNA damage in patients with impaired glucose regulation and newly diagnosed type 2 diabetes,” Clinical Science, vol. 112, no. 11-12, pp. 599–606, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. B. Halliwell, “The antioxidant paradox,” The Lancet, vol. 355, no. 9210, pp. 1179–1180, 2000. View at Google Scholar · View at Scopus
  13. A. Yessoufou, N. Soulaimann, S. A. Merzouk et al., “N-3 fatty acids modulate antioxidant status in diabetic rats and their macrosomic offspring,” International Journal of Obesity, vol. 30, no. 5, pp. 739–750, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. G. Cao, H. M. Alessio, and R. G. Cutler, “Oxygen-radical absorbance capacity assay for antioxidants,” Free Radical Biology and Medicine, vol. 14, no. 3, pp. 303–311, 1993. View at Publisher · View at Google Scholar · View at Scopus
  15. C. F. Semenkovich and J. W. Heinecke, “The mystery of diabetes and atherosclerosis: time for a new plot,” Diabetes, vol. 46, no. 3, pp. 327–334, 1997. View at Google Scholar · View at Scopus
  16. A. H. Lichtenstein, E. Kennedy, and P. Barrier, “Dietary fat consumption and health,” Nutrition Reviews, vol. 56, pp. 3–19, 1998. View at Google Scholar
  17. B. A. Nassar, Y. S. Huang, M. S. Manku, U. N. Das, N. Morse, and D. F. Horrobin, “The influence of dietary manipulation with n-3 and n-6 fatty acids on liver and plasma phospholipid fatty acids in rats,” Lipids, vol. 21, no. 10, pp. 652–656, 1986. View at Publisher · View at Google Scholar · View at Scopus
  18. T. Hünkar, F. Aktan, A. Ceylan, and Ç. Karasu, “Effects of cod liver oil on tissue antioxidant pathways in normal and streptozotocin-diabetic rats,” Cell Biochemistry and Function, vol. 20, no. 4, pp. 297–302, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. H. Merzouk and N. A. Khan, “Implication of lipids in macrosomia of diabetic pregnancy: can n-3 polyunsaturated fatty acids exert beneficial effects?” Clinical Science, vol. 105, no. 5, pp. 519–529, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. N. L. Gelardi, C.-J. M. Cha, and W. Oh, “Glucose metabolism in adipocytes of obese offspring of mild hyperglycemic rats,” Pediatric Research, vol. 28, no. 6, pp. 641–645, 1990. View at Google Scholar · View at Scopus
  21. B. Guermouche, A. Yessoufou, N. Soulimane et al., “n-3 fatty acids modulate T-cell calcium signaling in obese macrosomic rats,” Obesity Research, vol. 12, no. 11, pp. 1744–1753, 2004. View at Google Scholar · View at Scopus
  22. H. Merzouk, S. Madani, A. Hichami et al., “Impaired lipoprotein metabolism in obese offspring of streptozotocin-induced diabetic rats,” Lipids, vol. 37, no. 8, pp. 773–781, 2002. View at Google Scholar · View at Scopus
  23. J.-M. R. Frenoux, E. D. Prost, J. L. Belleville, and J. L. Prost, “A polyunsaturated fatty acid diet lowers blood pressure and improves antioxidant status in spontaneously hypertensive rats,” Journal of Nutrition, vol. 131, no. 1, pp. 39–45, 2001. View at Google Scholar · View at Scopus
  24. L. Sjoblom and A. Eklund, “Determination of HDL2 cholesterol by precipitation with dextran sulfate and magnesium chloride: establishing optimal conditions for rat plasma,” Lipids, vol. 24, no. 6, pp. 532–534, 1989. View at Publisher · View at Google Scholar · View at Scopus
  25. Z. Zaman, P. Fielden, and P. G. Frost, “Simultaneous determination of vitamins A and E and carotenoids in plasma by reversed-phase HPLC in elderly and younger subjects,” Clinical Chemistry, vol. 39, no. 11, pp. 2229–2234, 1993. View at Google Scholar · View at Scopus
  26. C. Courderot-Masuyer, J. J. Lahet, B. Verges, J. M. Brun, and L. Rochette, “Ascorbyl free radical release in diabetic patients,” Cellular and Molecular Biology, vol. 46, no. 8, pp. 1397–1401, 2000. View at Google Scholar · View at Scopus
  27. J. Nourooz-Zadeh, J. Tajaddini-Sarmadi, K. L. E. Ling, and S. P. Wolff, “Low-density lipoprotein is the major carrier of lipid hydroperoxides in plasma—relevance to determination of total plasma lipid hydroperoxide concentrations,” Biochemical Journal, vol. 313, no. 3, pp. 781–786, 1996. View at Google Scholar · View at Scopus
  28. R. L. Levine, D. Garland, C. N. Oliver et al., “Determination of carbonyl content in oxidatively modified proteins,” Methods in Enzymology, vol. 186, pp. 464–478, 1990. View at Publisher · View at Google Scholar · View at Scopus
  29. R. A. Rabini, M. Tesei, T. Galeazzi, N. Dousset, G. Ferretti, and L. Mazzanti, “Increased susceptibility to peroxidation of VLDL from non-insulin-dependent diabetic patients: a possible correlation with fatty acid composition,” Molecular and Cellular Biochemistry, vol. 199, no. 1-2, pp. 63–67, 1999. View at Publisher · View at Google Scholar · View at Scopus
  30. A. F. S. A. Habeeb, “Determination of free amino groups in proteins by trinitrobenzenesulfonic acid,” Analytical Biochemistry, vol. 14, no. 3, pp. 328–336, 1966. View at Google Scholar · View at Scopus
  31. J. Folch, M. Lees, and G. H. Sloane-Stanley, “A simple method for the isolation and purification of total lipides from animal tissues,” The Journal of Biological Chemistry, vol. 226, no. 1, pp. 497–509, 1957. View at Google Scholar · View at Scopus
  32. H. T. Slover and E. Lanza, “Quantitative analysis of food fatty acids by capillary gas chromatography,” Journal of the American Oil Chemists' Society, vol. 56, no. 12, pp. 933–943, 1979. View at Publisher · View at Google Scholar · View at Scopus
  33. Ö. Yilmaz, Y. Özkan, M. Yildirim, A. I. Öztürk, and Y. Erşan, “Effects of alpha lipoic acid, ascorbic acid-6-palmitate, and fish oil on the glutathione, malonaldehyde, and fatty acids levels in erythrocytes of streptozotocin induced diabetic male rats,” Journal of Cellular Biochemistry, vol. 86, no. 3, pp. 530–539, 2002. View at Publisher · View at Google Scholar · View at Scopus
  34. N. A. Soulimane-Mokhtari, B. Guermouche, A. Yessoufou et al., “Modulation of lipid metabolism by n-3 polyunsaturated fatty acids in gestational diabetic rats and their macrosomic offspring,” Clinical Science, vol. 109, no. 3, pp. 287–295, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. R. A. Vileisis and W. Oh, “Enhanced fatty acid synthesis in hyperinsulinemic rat fetuses,” Journal of Nutrition, vol. 113, no. 2, pp. 246–252, 1983. View at Google Scholar · View at Scopus
  36. T. Pelikánová, L. Kazdová, S. Chvojková, and J. Base, “Serum phospholipid fatty acid composition and insulin action in type 2 diabetic patients,” Metabolism, vol. 50, no. 12, pp. 1472–1478, 2001. View at Google Scholar
  37. M. Bensellam, D. R. Laybutt, and J.-C. Jonas, “The molecular mechanisms of pancreatic β-cell glucotoxicity: recent findings and future research directions,” Molecular and Cellular Endocrinology, vol. 364, no. 1-2, pp. 1–27, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. C. R. Sirtori and C. Galli, “N-3 fatty acids and diabetes,” Biomedicine and Pharmacotherapy, vol. 56, no. 8, pp. 397–406, 2002. View at Publisher · View at Google Scholar · View at Scopus
  39. L. O. Medina, C. A. Veloso, É. de Abreu Borges et al., “Determination of the antioxidant status of plasma from type 2 diabetic patients,” Diabetes Research and Clinical Practice, vol. 77, no. 2, pp. 193–197, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. S. T. Mayne, “Antioxidant nutrients and chronic disease: use of biomarkers of exposure and oxidative stress status in epidemiologic research,” Journal of Nutrition, vol. 133, no. 3, pp. 933S–940S, 2003. View at Google Scholar · View at Scopus
  41. J. Cederberg, S. Basu, and U. J. Eriksson, “Increased rate of lipid peroxidation and protein carbonylation in experimental diabetic pregnancy,” Diabetologia, vol. 44, no. 6, pp. 766–774, 2001. View at Publisher · View at Google Scholar · View at Scopus
  42. S. Chesne, P. Rondeau, S. Armenta, and E. Bourdon, “Effects of oxidative modifications induced by the glycation of bovine serum albumin on its structure and on cultured adipose cells,” Biochimie, vol. 88, no. 10, pp. 1467–1477, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. S. H. A. Diepeveen, G. W. H. E. Verhoeven, J. van der Palen et al., “Effects of atorvastatin and vitamin E on lipoproteins and oxidative stress in dialysis patients: a randomised-controlled trial,” Journal of Internal Medicine, vol. 257, no. 5, pp. 438–445, 2005. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Liguori, P. Abete, J. M. Hayden et al., “Effect of glycaemic control and age on low-density lipoprotein susceptibility to oxidation in diabetes mellitus type 1,” European Heart Journal, vol. 22, no. 22, pp. 2075–2084, 2001. View at Publisher · View at Google Scholar · View at Scopus
  45. C. Feillet, B. Roche, I. Tauveron et al., “Susceptibility to oxidation and physicochemical properties of LDL in insulin-dependent diabetics,” Atherosclerosis, vol. 136, no. 2, pp. 405–407, 1998. View at Publisher · View at Google Scholar · View at Scopus
  46. J. V. Hunt, C. C. T. Smith, and S. P. Wolff, “Autoxidative glycosylation and possible involvement of peroxides and free radicals in LDL modification by glucose,” Diabetes, vol. 39, no. 11, pp. 1420–1424, 1990. View at Google Scholar · View at Scopus
  47. E. D. Schleicher, E. Wagner, and A. G. Nerlich, “Increased accumulation of the glycoxidation product N(ε)- (carboxymethyl)lysine in human tissues in diabetes and aging,” The Journal of Clinical Investigation, vol. 99, no. 3, pp. 457–468, 1997. View at Google Scholar · View at Scopus
  48. H. Esterbauer, G. Striegl, H. Phul, and M. Rotheneder, “Continuous monitoring of in vitro oxidation of human low density lipoprotein,” Free Radical Research Communications, vol. 6, no. 1, pp. 67–75, 1989. View at Google Scholar · View at Scopus
  49. G. Aldini, I. Dalle-Donne, R. M. Facino, A. Milzani, and M. Carini, “Intervention strategies to inhibit protein carbonylation by lipoxidation-derived reactive carbonyls,” Medicinal Research Reviews, vol. 27, no. 6, pp. 817–868, 2007. View at Publisher · View at Google Scholar · View at Scopus